Efficacy and Safety of a Botanical Formula Fuzheng Huayu for Hepatic Fibrosis in Patients with CHC: Results of a Phase 2 Clinical Trial

BACKGROUND: Hepatitis C virus (HCV) is a common cause of progressive hepatic fibrosis, cirrhosis, and hepatocellular carcinoma worldwide. Despite the availability of effective direct-acting antivirals, patients often have significant hepatic fibrosis at the time of diagnosis due to delay in diagnosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassanein, Tarek, Tai, Dean, Liu, Chenghai, Box, Terry D., Tong, Myron J., Rossaro, Lorenzo, Pozza, Renee, Glenn, Jeffrey S., Cheung, Ramsey, Hemaidan, Ammar, He, Yingchun, Behling, Cynthia, Hu, Xiqi, Makhlouf, Hala, Fan, Haina, Ren, Yayun, Khim Chng, Elaine Lay, Liu, Ping, Vierling, John M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307334/
https://www.ncbi.nlm.nih.gov/pubmed/35873630
http://dx.doi.org/10.1155/2022/4494099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307334/
https://www.ncbi.nlm.nih.gov/pubmed/35873630
http://dx.doi.org/10.1155/2022/4494099

Ejemplares similares